Money Investment
            

Geron Corporation - Common Stock

Stock Symbol:GERN

Public, NASDAQ:GERN

NASDAQ Global Market

GERN Stock Charts


Geron Completes Enrollment in Phase 2 Clinical Trial of Imetelstat in Breast ...
Date: Thu, 02 Feb 2012 22:06:29 GMT

Tags:

Geron Completes Enrollment in Phase 2 Clinical Trial of Imetelstat in Breast ...
Reuters - Feb 2, 2012
MENLO PARK, Calif., February 2, 2012 - Geron Corporation (Nasdaq: GERN) today announced that the company has completed enrollment in the randomized Phase 2 clinical trial of imetelstat, in combination with paclitaxel, in patients with locally recurrent ...

Key Biotechnology Risers and Fallers at NASDAQ – (MITI, OXGN, GERN, STEM, AMGN ...
Date: Fri, 27 Jan 2012 14:20:02 GMT

Tags:

Key Biotechnology Risers and Fallers at NASDAQ – (MITI, OXGN, GERN, STEM, AMGN ...
Galaxy Stocks - Jan 27, 2012
Amgen Inc., recently decided to acquire Micromet Inc. (NASDAQ:MITI) for the amount of $1.16 billion, faced a drop after announcing lower-than-estimated profit for the fourth quarter because of a decline in its anemia drugs sales while Micromet shares ...

Bearish Bettors Eye Geron's Longer-Term Puts
Date: Fri, 20 Jan 2012 20:11:55 GMT

Tags:

Bearish Bettors Eye Geron's Longer-Term Puts
Schaeffers Research (blog) - Jan 20, 2012
Bears have flocked toward Geron Corporation (GERN - 1.74) today, as approximately 2000 puts have crossed the tape so far, which is seven times above the norm.

InvestorStemCell.com : Is Validation of Regenerative Medicine Upon the World ...
Date: Thu, 19 Jan 2012 18:30:22 GMT

Tags:

InvestorStemCell.com : Is Validation of Regenerative Medicine Upon the World ...
Emailwire (press release) - Jan 19, 2012
A revolution in biotechnology is upon the world. It has been quietly playing out in labs across the world for decades. The paradigm shift in healthcare through regenerative medicine is here.

Geron Corporation Initiates Phase 2 Trial Of GRN1005 In Brain Metastases From Breast Cancer
Date: Mon, 12 Dec 2011 12:30:00 GMT

Tags:

Geron Corporation Initiates Phase 2 Trial Of GRN1005 In Brain Metastases From Breast Cancer
Reuters Key Development - Dec 12, 2011

Buy, Sell, or Hold: Geron
Date: Tue, 07 Feb 2012 18:37:31 GMT

Tags:


Geron: Mea Culpa
Date: Mon, 06 Feb 2012 18:20:54 GMT

Tags:


Geron Completes Enrollment in Phase 2 Clinical Trial of Imetelstat in Breast Cancer
Date: Thu, 02 Feb 2012 21:32:03 GMT

Tags:

[Thomson Reuters ONE] - MENLO PARK, Calif., February 2, 2012 - Geron Corporation (Nasdaq: GERN - News) today announced that the company has completed enrollment in the randomized Phase 2 clinical trial of imetelstat, in combination ...
Former Geron CFO gets $750K severance, $400-an-hour consulting gig
Date: Thu, 02 Feb 2012 15:07:05 GMT

Tags:


Former Geron CFO gets $750K severance, $400-an-hour consulting gig
Date: Wed, 01 Feb 2012 23:09:28 GMT

Tags:


Money Investment Provides Stock Market Headlines, Stock Quotes and Charts, Stock Exchange News and Prices.

Nasdaq   Dow Jones   BigCharts   E*Trade   ScotTrade   RSS Directory of Stock Quotes & Investing

© 2006 - 2012 MONEY INVESTMENT. ALL RIGHTS RESERVED.